Maintenance of diet participation in individuals with spinal cord injury: effect on mood and neuropathic pain

被引：6

作者：

Allison D.J. ^{[1
,2
]}

Ditor D.S. ^{[1
,2
]}

机构：

[1] Department of Kinesiology, Brock University, St Catharines, L2S 3A1, ON

[2] Brock-Niagara Centre for Health and Well-being, St Catharines, L2T 1W4, ON

来源：

Spinal Cord Series and Cases | / 4卷 / 1期

关键词：

D O I：

10.1038/s41394-018-0131-2

中图分类号：

学科分类号：

摘要：

Study design:: One-year follow-up of a randomized clinical trial. Objectives:: Examine voluntary dietary compliance 1 year following the cessation of the intervention and the persistence of accrued benefits related to neuropathic pain and mood. Setting:: Outpatient rehabilitation program within the Niagara region. Methods:: Five individuals (4 female, 1 male; age 50.6 ± 11.8 years) with chronic SCI (C5-L3; ISNCSCI: A–D; 7–40 years post injury) who had previously completed a 3-month anti-inflammatory diet were reassessed after 1 year for measures related to dietary compliance, CES-D scores of depression, and NPQ scores of neuropathic pain. Results:: There was a significant reduction in diet compliance at the 1-year follow-up in comparison to the end of the dietary intervention at 3 months (92.6% versus 43.0%, p < 0.01). CES-D scores showed a trend toward an increase from 3 months to follow-up (8.0 versus 21.4, p =.10) whereby follow-up CES-D scores were no longer statistically different from baseline (p = 0.74). Sensory NPQ scores showed no significant change from 3 months to follow-up (25.2 versus 29.1, p = 0.42) and remained significantly lower than baseline (p = 0.02). Affective NPQ scores were significantly increased from 3 months to follow-up (27.7 versus 40.1, p = 0.05). Sensitivity NPQ scores showed no significant change from 3 month to follow-up (28.2 versus 33.5, p = 0.34), but returned to a score that was statistically similar to baseline (p = 0.15). Conclusions:: These results emphasize the importance of continued compliance to a diet with anti-inflammatory properties for the purposes of maintaining benefits related to mood and neuropathic pain in individuals with SCI. Sponsorship:: This study was supported by the Ontario Neurotrauma Foundation. © 2018, International Spinal Cord Society.

引用

共 14 条

[1]

Siddall P.J., McClelland J.M., Rutkowski S.B., Cousins M.J., A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury, Pain, 103, pp. 249-257, (2003)

[2]

Craig A., Tran Y., Middleton J., Psychological morbidity and spinal cord injury: a systematic review, Spinal Cord, 47, pp. 108-114, (2009)

[3]

Kennedy P., Rogers B.A., Anxiety and depression after spinal cord injury: a longitudinal analysis, Arch Phys Med Rehabil, 81, pp. 932-937, (2000)

[4]

Woolf C.J., Mannion R.J., Neuropathic pain: aetiology, symptoms, mechanisms, and management, Lancet, 353, pp. 1959-1964, (1999)

[5]

Allison D.J., Ditor D.S., The common inflammatory etiology of depression and cognitive impairment: a therapeutic target, J Neuroinflamm, 11, (2014)

[6]

Watkins L.R., Maier S.F., Goehler L.E., Cytokine-to-brain communication: a review & analysis of alternative mechanisms, Life Sci, 57, pp. 1011-1026, (1995)

[7]

Tulsky D.S., Kisala P.A., Victorson D., Tate D.G., Heinemann A.W., Charlifue S., Et al., Overview of the Spinal Cord Injury--Quality of Life (SCI-QOL) measurement system, J Spinal Cord Med, 38, pp. 257-269, (2015)

[8]

Hagen E.M., Rekand T., Management of neuropathic pain associated with spinal cord injury, Pain Ther, 4, pp. 51-65, (2015)

[9]

Penn E., Tracy D.K., The drugs don’t work? Antidepressants and the current and future pharmacological management of depression, Ther Adv Psychopharmacol, 2, pp. 179-188, (2012)

[10]

Allison D.J., Thomas A., Beaudry K., Ditor D.S., Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial, J Neuroinflamm, 13, (2016)

← 1 2 →